APA ציטוט

Troya, J., Ryan, P., Ribera, E., Podzamczer, D., Hontañón, V., Terrón, J. A., . . . Imaz, A. (2017). Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study. PLoS One.

Citação norma Chicago

Troya, Jesús, et al. "Correction: Abacavir/Lamivudine Plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study." PLoS One 2017.

ציטוט MLA

Troya, Jesús, et al. "Correction: Abacavir/Lamivudine Plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study." PLoS One 2017.